| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.67 | 0.7 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.46 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.39 | 0.04 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.28 | 1e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 0.0002 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.27 | 0.0007 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |